Zobrazeno 1 - 10
of 461
pro vyhledávání: '"Stuart J. Schnitt"'
Autor:
Yujing J. Heng, Gabrielle M. Baker, Valerie J. Fein-Zachary, Yaileen D. Guzman-Arocho, Vanessa C. Bret-Mounet, Erica S. Massicott, Vanda F. Torous, Stuart J. Schnitt, Sy Gitin, Paul Russo, Adam M. Tobias, Richard A. Bartlett, Gopal Varma, Despina Kontos, Lusine Yaghjyan, Michael S. Irwig, Jennifer E. Potter, Gerburg M. Wulf
Publikováno v:
Breast Cancer Research, Vol 26, Iss 1, Pp 1-11 (2024)
Abstract Background The effect of gender-affirming testosterone therapy (TT) on breast cancer risk is unclear. This study investigated the association between TT and breast tissue composition and breast tissue density in trans masculine individuals (
Externí odkaz:
https://doaj.org/article/6fadfe83e91c42a2b3f583dd12169e41
Autor:
Jennifer L. Guerriero, Jia-Ren Lin, Ricardo G. Pastorello, Ziming Du, Yu-An Chen, Madeline G. Townsend, Kenichi Shimada, Melissa E. Hughes, Siyang Ren, Nabihah Tayob, Kelly Zheng, Shaolin Mei, Alyssa Patterson, Krishan L. Taneja, Otto Metzger, Sara M. Tolaney, Nancy U. Lin, Deborah A. Dillon, Stuart J. Schnitt, Peter K. Sorger, Elizabeth A. Mittendorf, Sandro Santagata
Publikováno v:
npj Breast Cancer, Vol 10, Iss 1, Pp 1-22 (2024)
Abstract Emerging data suggests that HER2 intratumoral heterogeneity (ITH) is associated with therapy resistance, highlighting the need for new strategies to assess HER2 ITH. A promising approach is leveraging multiplexed tissue analysis techniques s
Externí odkaz:
https://doaj.org/article/3efb1bd4ddfe4838842869755c17c107
Autor:
Judith Sandbank, Guillaume Bataillon, Alona Nudelman, Ira Krasnitsky, Rachel Mikulinsky, Lilach Bien, Lucie Thibault, Anat Albrecht Shach, Geraldine Sebag, Douglas P. Clark, Daphna Laifenfeld, Stuart J. Schnitt, Chaim Linhart, Manuela Vecsler, Anne Vincent-Salomon
Publikováno v:
npj Breast Cancer, Vol 8, Iss 1, Pp 1-11 (2022)
Abstract Breast cancer is the most common malignant disease worldwide, with over 2.26 million new cases in 2020. Its diagnosis is determined by a histological review of breast biopsy specimens, which can be labor-intensive, subjective, and error-pron
Externí odkaz:
https://doaj.org/article/e224bbfaed794f779e7f34d5d8bace6b
Autor:
Romualdo Barroso-Sousa, Tanya E. Keenan, Tianyu Li, Nabihah Tayob, Lorenzo Trippa, Ricardo G. Pastorello, Edward T. Richardson III, Deborah Dillon, Zohreh Amoozgar, Beth Overmoyer, Stuart J. Schnitt, Eric P. Winer, Elizabeth A. Mittendorf, Eliezer Van Allen, Dan G. Duda, Sara M. Tolaney
Publikováno v:
npj Breast Cancer, Vol 7, Iss 1, Pp 1-8 (2021)
Abstract This single-arm phase II study investigated the efficacy and safety of cabozantinib combined with nivolumab in metastatic triple-negative breast cancer (mTNBC). The primary endpoint was objective response rate (ORR) by RECIST 1.1. Biopsies a
Externí odkaz:
https://doaj.org/article/1588be2699b0434ab5c7f6e1a6080ecb
Publikováno v:
npj Breast Cancer, Vol 7, Iss 1, Pp 1-6 (2021)
Abstract Data on the risk of breast cancer following a benign breast disease (BBD) diagnosis were derived predominantly from populations of women biopsied before the widespread use of mammographic screening and in whom these lesions were mostly incid
Externí odkaz:
https://doaj.org/article/7b27ac20b33b4b9c8fa08805db1d0012
Autor:
Aatish Thennavan, Francisco Beca, Youli Xia, Susana Garcia-Recio, Kimberly Allison, Laura C. Collins, Gary M. Tse, Yunn-Yi Chen, Stuart J. Schnitt, Katherine A. Hoadley, Andrew Beck, Charles M. Perou
Publikováno v:
Cell Genomics, Vol 1, Iss 3, Pp 100067- (2021)
Summary: Breast cancer is classified into multiple distinct histologic types, and many of the rarer types have limited characterization. Here, we extend The Cancer Genome Atlas Breast Cancer (TCGA-BRCA) dataset with additional histologic type annotat
Externí odkaz:
https://doaj.org/article/670ecf51d03e44c290046f426d20e094
Autor:
Kevin H. Kensler, Meredith M. Regan, Yujing J. Heng, Gabrielle M. Baker, Michael E. Pyle, Stuart J. Schnitt, Aditi Hazra, Roswitha Kammler, Beat Thürlimann, Marco Colleoni, Giuseppe Viale, Myles Brown, Rulla M. Tamimi
Publikováno v:
Breast Cancer Research, Vol 21, Iss 1, Pp 1-11 (2019)
Abstract Background The androgen receptor (AR) is an emerging prognostic marker and therapeutic target in breast cancer. AR is expressed in 60–80% of breast cancers, with higher prevalence among estrogen receptor-positive (ER+) tumors. Androgen tre
Externí odkaz:
https://doaj.org/article/7ef146cc6971484fbc4ebd6c88f2c0e4
Autor:
Neelam V. Desai, Vanda Torous, Joel Parker, James T. Auman, Gary B. Rosson, Cassandra Cruz, Charles M. Perou, Stuart J. Schnitt, Nadine Tung
Publikováno v:
Breast Cancer Research, Vol 20, Iss 1, Pp 1-6 (2018)
Abstract The 2013 update of the American Society of Clinical Oncology-College of American Pathologists (ASCO-CAP) human epidermal growth factor receptor 2 (HER2) testing guidelines recommend using an alternative chromosome 17 probe assay to resolve H
Externí odkaz:
https://doaj.org/article/9fff4b43dfaf4987943633fbd24db5e3
Autor:
Stuart J. Schnitt, Laura C. Collins
Your practical aid to confident diagnosis! Biopsy Interpretation of the Breast, 3rd Edition helps you correctly identify the full range of pathologic alterations encountered in breast tissue. The intuitive organization approaches diagnosis the way yo
Autor:
Alison, Laws, Ricardo, Pastorello, Tanujit, Dey, Samantha, Grossmith, Claire, King, Monica, McGrath, Stuart J, Schnitt, Elizabeth A, Mittendorf, Tari, King
Publikováno v:
Annals of Surgical Oncology. 29:7726-7736
Additional risk-stratification measures are needed in breast cancer patients with residual disease after neoadjuvant chemotherapy (NAC). We aimed to describe oncologic outcomes in a modern cohort treated with NAC, and evaluate the prognostic value of